-
601
-
602
Fate and transport of endocrine disrupting compounds on nanofiltration and reverse osmosis processes
Published 2009“…Endocrine disrupting compounds (EDCs) can enter the environment, disperse, and persist at trace levels that can cause adverse health effects on humans and wildlife. …”
Get full text
Final Year Project (FYP) -
603
Destruction of endocrine disruptor chemicals (resorcinol) using UV-C radiation
Published 2018“…The presence of Endocrine Disruptor Compounds (EDCs) in waste water treatment system is a worrying issue as EDCs are potentially hazardous to the environment and human health. …”
Get full text
Final Year Project (FYP) -
604
-
605
The predictive value of CK19 and CD99 in pancreatic endocrine tumors.
Published 2006“…Prediction of behavior in pancreatic endocrine tumors (PETs) is reliant on clinicopathologic features. …”
Journal article -
606
The role of molecular genetics in screening for multiple endocrine neoplasia type 1.
Published 1994Journal article -
607
Molecular genetics and patient management of multiple endocrine neoplasia type I
Published 2001“…Multiple endocrine neoplasia type 1 (MEN-1) is an autosomal dominant disorder characterized by the combined occurrence of tumours of the parathyroids, pancreatic islet cells and anterior pituitary. …”
Journal article -
608
Exocrine or endocrine? A circulating pancreatic elastase that regulates glucose homeostasis
Published 2019Journal article -
609
HYPOPHAGIC, ENDOCRINE AND SUBJECTIVE RESPONSES TO M-CHLOROPHENYLPIPERAZINE IN HEALTHY-MEN AND WOMEN
Published 1995Journal article -
610
Pancreatic endocrine tumour with cytoplasmic keratin whorls. Is the term "rhabdoid" appropriate?
Published 2004Journal article -
611
Molecular genetic mapping of the multiple endocrine neoplasia type 1 locus.
Published 1992“…Familial multiple endocrine neoplasia type 1 (MEN 1) is an autosomal dominant disorder characterized by the combined occurrence of tumors of the parathyroid glands, the endocrine pancreas, and the pituitary gland. …”
Journal article -
612
Clinical studies of multiple endocrine neoplasia type 1 (MEN1)
Published 1996“…Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder characterized by the combined occurrence of parathyroid, pancreatic islet and anterior pituitary tumours. …”
Journal article -
613
Prolactinoma presenting in identical twins with multiple endocrine neoplasia type 1.
Published 1996“…Multiple endocrine neoplasia type one (MEN 1) is characterized by tumours of the parathyroid glands, pancreatic islet cells and the anterior pituitary and follows an autosomal dominant pattern of inheritance. …”
Journal article -
614
The molecular basis of parathyroid tumours in multiple endocrine neoplasia type 1
Published 1990Journal article -
615
Gene modifiers and novel therapies for multiple endocrine neoplasia type 1
Published 2012“…<p>Multiple Endocrine Neoplasia Type 1 (MEN1) is an autosomal dominant disorder characterized by the combined occurrence of pituitary, pancreatic islet and parathyroid tumours. …”
Thesis -
616
Existence of long-lasting experience-dependent plasticity in endocrine cell networks
Published 2012“…As such, long-lasting experience-dependent plasticity is an important feature of endocrine cell networks and underlies functional adaptation of hormone release.…”
Journal article -
617
Pancreas transplantation with systemic endocrine drainage leads to improvement in lipid metabolism.
Published 1994Journal article -
618
Pancreatic endocrine tumour with ductules: further observations of an unusual histological subtype.
Published 2006“… AIMS: Pancreatic endocrine tumours (PET) containing ductules are an uncommon histological variant. …”
Journal article -
619
Identification of the multiple endocrine neoplasia type 1 (MEN1) gene
Published 1997“…Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder characterised by tumours of the parathyroids, pancreas and anterior pituitary that represents one of the familial cancer syndromes. …”
Journal article -
620
Analysis of endocrine autoimmunity by cloning human T lymphocytes from target tissues
Published 1987Journal article